Advertisement

A common blood pressure drug has been withdrawn from the US market

 

A common blood pressure drug has been withdrawn from the US market

Breckenridge Pharmaceutical announced a recall of a batch of the drug "propranolol" used to treat high blood pressure and heart problems, due to suspicions that it contained metal fragments.

Hot Topics

The company stated that the 60 mg white capsules, manufactured by Adare Pharma, may contain metal fragments and, if swallowed, could cause injuries to the tissues of the mouth, esophagus, stomach, or intestines. No injuries or side effects have been reported to date.

The recalled batch was distributed throughout the United States between October 26 and November 4 in packages containing 100 capsules each.

The packages bear an expiry date of May 2029 and batch number PK25110035.

The company urged those who were prescribed the medication from this batch to stop taking it immediately and to contact their doctor. It also requested that any unused quantity be returned to the pharmacy that dispensed the medication.

For its part, the U.S. Food and Drug Administration urged anyone experiencing symptoms or complications related to the drug to consult a doctor and report the condition via the MedWatch program.

Propranolol is prescribed to approximately 10 million Americans. It is a beta-blocker that works by reducing the effects of the stress hormones adrenaline and noradrenaline, thus easing the burden on the heart and lowering heart rate and blood pressure. It is also prescribed to treat chest pain, heart rhythm disorders, and certain other cardiac conditions, and is used for migraines and essential tremor.

It is not yet clear how the metal fragments got into the capsules, but such cases are often linked to problems with manufacturing equipment, raw material contamination, or packaging defects.

This recall is the latest in a series of blood pressure medication recalls. Last month, Teva Pharmaceuticals US and its distributor Amerisource Health Services recalled more than 580,000 packs of Prazosin hydrochloride due to concerns that it contained compounds linked to cancer in animal studies. Chlorthalidone tablets were also recalled earlier this year due to a dissolving issue, as were Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets for the same reason.

what is your opinion on this news ?do let us know in the comments on tha comment box 

if you liked this news article please share on friends & family & don't forget to follow on website & social media

Post a Comment

Previous Post Next Post
Advertisement
Advertisement
Advertisement